1 2 3 13
Therapeutic Strategies in Dermatology

Lupus: Key Points

…s Lupus is a disease that presents across a broad spectrum of cutaneous and systemic manifestations. It may be cutaneous-only or systemic with cutaneous manifestations; some patients with systemic lupus do not have cutaneous involvement. Diagnostic…

Therapeutic Strategies in Dermatology

Borreliosis (Lyme Disease): Key Points

…th various Borrelia species causes borreliosis, which may have cutaneous and systemic manifestations. This infection is transmitted through bites of the Ixodes species of ticks. Early Lyme disease (erythema chronicum migrans) and late Lyme disease (a…

Therapeutic Strategies in Dermatology

Creeping Eruption, Larva Migrans, and Larva Currens: Overview

Treatment Cutaneous Larva Migrans (CLM) [The treatment for larva currens is somewhat different so the two diseases are discussed separately.] Cutaneous larva migrans is due to animal (usually canine) hookworm. It presents as serpiginous papules on t…

Therapeutic Strategies in Dermatology

Kaposi’s Sarcoma: Overview

…. The following staging system may be used: Stage I: Localized cutaneous (fewer than 10 lesions, or one anatomic region); Stage II: Disseminated cutaneous (more than 10 lesions, or more than one anatomic area); Stage III: Visceral only; Stage IV: Cut…

Therapeutic Strategies in Dermatology

Leishmaniasis: Overview

…e infection was acquired. Leishmaniasis occurs in three forms: cutaneous, mucocutaneous, and visceral. Only the therapy of cutaneous leishmaniasis is discussed here. Treatment Old World Leishmaniasis The following therapy may not apply to disease acq…

Therapeutic Strategies in Dermatology

Cutaneous T-Cell Lymphoma/ Mycosis Fungoides: Overview

…ary team earlier rather than later to insure the best possible cutaneous response. Side effects are those of the agents employed, and patients must be carefully monitored for therapeutic complications. Patients with cutaneous T-cell lymphoma are comm…

1 2 3 13